Literature DB >> 3081348

C5a fragment of bovine complement. Purification, bioassays, amino-acid sequence and other structural studies.

R Gennaro, T Simonic, A Negri, C Mottola, C Secchi, S Ronchi, D Romeo.   

Abstract

C5a and des-Arg-C5a have been purified from bovine serum in milligram amounts. The progress of the purification was followed by measuring the chemotactic activity of the complement fragments. The two polypeptides induce activation of neutrophil-oriented locomotion and secretion with very similar dose/response effects. After preparing a rabbit antiserum to bovine C5a/des-Arg-C5a, a competitive enzyme-linked immunosorbent assay (ELISA) was set up for the detection of C5a from 5 ng/mol to 1 microgram/ml. The complete primary structure of bovine C5a, which consists of 74 amino acids, has been determined by sequence analysis of the tryptic peptides, aligned by peptides derived from a chymotryptic digest, and by partially sequencing the intact molecule. Bovine C5a has a sequence homology of 78% and 70% with porcine and human C5a, respectively, reacts with an antiserum to porcine C5a and is recognized by cell surface receptors on human neutrophils. Finally, the secondary structure of bovine C5a was investigated by circular dicroic spectroscopy and predicted from the amino acid sequence. A comparison of the content and distribution of alpha-helical and/or hydropathic regions, suggests that the three-dimensional structure of C5a might be modeled from the known crystal structure of the homologous C3a molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081348     DOI: 10.1111/j.1432-1033.1986.tb09460.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

1.  Consequences of interference of milk with chemoattractants for enzyme-linked immunosorbent assay quantifications.

Authors:  P Rainard
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

2.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Fc microparticles can modulate the physical extent and magnitude of complement activity.

Authors:  Brandon Alexander Holt; Michael C Bellavia; Daniel Potter; David White; Sean R Stowell; Todd Sulchek
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

4.  Complement fragment C5a and inflammatory cytokines in neutrophil recruitment during intramammary infection with Escherichia coli.

Authors:  D E Shuster; M E Kehrli; P Rainard; M Paape
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

Review 5.  Photodynamic Therapy and Immunity: An Update.

Authors:  Riddhi Falk-Mahapatra; Sandra O Gollnick
Journal:  Photochem Photobiol       Date:  2020-04-23       Impact factor: 3.421

6.  Restricted ability of group B streptococcal C5a-ase to inactivate C5a prepared from different animal species.

Authors:  J F Bohnsack; J K Chang; H R Hill
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Molecular analysis of the bovine anaphylatoxin C5a receptor.

Authors:  Sailasree Nemali; Daniel W Siemsen; Laura K Nelson; Peggy L Bunger; Craig L Faulkner; Pascal Rainard; Katherine A Gauss; Mark A Jutila; Mark T Quinn
Journal:  J Leukoc Biol       Date:  2008-05-14       Impact factor: 4.962

8.  Calcium mobilization in C5a-stimulated adult and newborn bovine neutrophils.

Authors:  M Doré; D O Slauson; M M Suyemoto; N R Neilsen
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

9.  Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency.

Authors:  L Cui; D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

10.  A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.

Authors:  W Bautsch; T Kretzschmar; T Stühmer; A Kola; M Emde; J Köhl; A Klos; D Bitter-Suermann
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.